SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055672
Filing Date
2024-05-08
Accepted
2024-05-08 16:13:19
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-20240331.htm   iXBRL 10-Q 1952064
2 EX-10.1 kpti-ex10_1.htm EX-10.1 38550
3 EX-10.2 kpti-ex10_2.htm EX-10.2 53034
4 EX-31.1 kpti-ex31_1.htm EX-31.1 11550
5 EX-31.2 kpti-ex31_2.htm EX-31.2 11586
6 EX-32.1 kpti-ex32_1.htm EX-32.1 6801
7 EX-32.2 kpti-ex32_2.htm EX-32.2 7082
8 GRAPHIC img175285707_0.jpg GRAPHIC 3833
  Complete submission text file 0000950170-24-055672.txt   7376753

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kpti-20240331.xsd EX-101.SCH 1123326
65 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20240331_htm.xml XML 1085458
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 24926227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)